Patients are being harmed by compounded semaglutide, and dosing errors appear to be the culprit. That’s what the FDA said in a letter that the agency sent out at the end of July.
Version: 20240731
Patients are being harmed by compounded semaglutide, and dosing errors appear to be the culprit. That’s what the FDA said in a letter that the agency sent out at the end of July.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.